Cleveland — Within3 has appointed Erin Mistry as chief executive officer to lead the life sciences technology company’s next phase of growth.
Mistry brings more than 20 years of experience in global biopharmaceutical commercialization and has helped launch and price more than 20 pharmaceutical products across eight therapeutic areas.
She most recently served as chief commercial officer at CorMedix, where she led the launch of DefenCath and helped the company reach break-even within six months and profitability in less than a year.
Mistry previously held senior leadership roles at Syneos Health and Jupiter Life Sciences and worked at MedImmune and AstraZeneca. She also serves on the Executive Policy Council at the Harvard T.H. Chan School of Public Health and is a member of the Pharma AI Council.
“Erin has spent her career on the front lines of launch and has firsthand experience of the downside of making real-time decisions with imperfect data and information. That visceral understanding that all customers also feel is exactly the perspective we need at Within3 as we scale our AI and analytics capabilities to meet the complexity our customers face every day,” said Jason Smith, Within3’s Chief Technology Officer.
Within3 provides a Launch Intelligence platform designed to help life sciences companies combine commercial, medical and field data, identify market changes and support decisions throughout the product launch process.
As CEO, Mistry will oversee the expansion of the company’s platform and services, with a focus on helping pharmaceutical teams turn fragmented information into actionable commercial intelligence.
“Erin hasn’t just supported the decisions our clients make — as a leader in Pharma, she’s made them. That firsthand perspective, now shaping Within3 from the top, will sharpen everything we do,” said Ian McKinnon, Managing Director, Global Head of Consulting.
“What sets Erin apart is rare: she’s run commercial launches, she’s built technology platforms, and she knows the consulting work that turns raw insight into the calls our clients actually have to make. Almost no leader has stood in all three places. That combination brings credibility and vision that will resonate across the industry,” said Aly Madjerich, Senior Vice President, Global Marketing.
“Over the course of my career, I’ve learned that success isn’t about having more information — it’s about having the right intelligence, the right technology, and the speed to act,” said Mistry. “Within3 is uniquely positioned to help life sciences organizations turn insights into action by connecting commercial, medical, and field teams around a shared understanding. I look forward to leading the company through its next phase, building on its strong foundation while continuing to innovate for our customers and help bring therapies to patients more effectively.”
